Science can improve health and wellbeing in so many ways, from the development of everyday convenience healthcare products through to life-saving medicines and vaccines.
More than 11,000 people work in R&D in our search for new medicines, vaccines and consumer healthcare products.
A Canadian R&D Leader
GSK has invested more than $2 billion since 2001 in Canadian pharmaceutical and vaccines R&D, ranking it among the top 10 contributors to R&D in Canada across all industries. In 2016 alone, GSK in Canada invested over $62 million to R&D.
- In 2017, GSK invested $13.2 million in conducting 31 clinical trials across Canada involving 1,921 subjects.
- In 2017, GSK supported 16 Investigator Sponsored Studies with physicians across Canada.
- In 2017, GSK sponsored approximately 30 Canadian research projects, focused on health economics and outcomes research, to support the scientific understanding of our medicines and vaccines in Canada.
Supporting R&D Innovation in Canada
To accelerate the discovery of new medicines and vaccines, we make collaboration part of our business model. Partnering with academic researchers and public organisations is a key part of our research efforts and we have a range of projects in place to allow us to work with and support new projects that fall within the specific areas of science we are interested in exploring.
In Canada, GSK is actively engaged in the support of research and innovation in the life sciences, and the commercialization of new technologies. GSK works actively with academic researchers, university industry liaison and technology transfer offices, and innovation hubs such as MaRS Innovation, the Centre for Drug Research and Development (CDRD), and the Quebec Consortium for Drug Development (CQDM), to identify exciting new opportunities in drug discovery and development for potential collaboration with GSK.
Sharing our research
As part of our commitment to transparency, we are reporting the results of all our research, where the outcomes are perceived to be positive or negative. You can read more about this commitment here.